Literature DB >> 11582586

Endothelin receptor antagonists in the treatment of prostate cancer.

J B Nelson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11582586     DOI： 10.1002/pros.1121

Source DB:  PubMed          Journal:  Prostate        ISSN： 0270-4137            Impact factor:   4.104


× No keyword cloud information.
  3 in total

Review 1.  Is urotensin-II the new endothelin?

Authors:  Janet J Maguire; Anthony P Davenport
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

2.  The endothelin B (ETB) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification.

Authors:  M Cemazar; I Wilson; V E Prise; K M Bell; S A Hill; G M Tozer
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

3.  The role of the endothelin axis in promoting epithelial to mesenchymal transition and lymph node metastasis in prostate adenocarcinoma.

Authors:  Sophia Papanikolaou; Vasiliki Bravou; Helen Papadaki; Kostis Gyftopoulos
Journal:  Urol Ann       Date:  2017 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.